Clinical Trial Update: Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating treosulfan versus melphalan conditioning followed by post-transplant cyclophosphamide in AML and MDS patients undergoing allog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Melphalan (Melphalan)
• Treosulfan (treosulfan)

Snippet

Sponsor: Technische Universität Dresden | Conditions: AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome) | Phase 2 | Status: NOT_YET_RECRUITING